AI drug development

Sales & Marketing

Improving patient engagement and drug development through AI...

Although it might seem like AI is the newest and hottest innovation in the industry, medical affairs professionals have been using some form of it for decades

R&D

Transforming drug development with AI

From streamlining clinical trials to evaluating drug repurposing possibilities for new patient populations and addressing critical supply chain challenges, 2024 will be the year artificial

Market Access

Six takeaways from JP Morgan 2024

With another JP Morgan in the rearview mirror, it’s time to take stock of the announcements, the presentations, and, above all, the vibes.

R&D

Solving the hit-to-lead selection challenge for novel target...

The drug target universe is expanding to include RNA and protein-protein interactions, but poor-quality data is holding back progress.

R&D

Future of generative AI in pharma

Talk of implementing automation and AI to enhance human capacity is dominating conversations.

News

BenevolentAI, AstraZeneca AI-based drug discovery collaborat...

BenevolentAI has discovered a second novel target for idiopathic pulmonary fibrosis (IPF), which AstraZeneca has added to its drug development portfolio, resulting in a milestone payment to the Lon